| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8217838 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 9 Pages |
Abstract
Hypofractionation use increased among low-risk older US breast cancer patients with publication and maturation of evidence from randomized trials, but overall use of this cost-saving approach remained low. This contrasts with the more rapid rate of adoption of IMRT in the same time period, a costly innovation supported by less strong evidence of benefit.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Reshma MD, DPhil, Aaron D. MD, Laura H. MS, Heather MD, Ronald C. MD, MPH,